Wettan Keeley Cain sold $558K of Gilead Sciences stock
By AlphaYouPublished Form 4
Cain Wettan Keeley M
Reporting filer
Wettan Keeley Cain reported selling 3,399 shares of Gilead Sciences, Inc. for about $558K ($164.11 a share on average). Form 4 filed Nov 10, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Nov 10, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Cain Wettan Keeley M | 2026-11-06 | S | Sale | 3399 | 164.11 | 5,360 | 4 days | Filed terms
|
Common Stock
- Owner
- Cain Wettan Keeley M
- Date
- 2026-11-06
- Code
- S
- Action
- Sale
- Quantity
- 3399
- Price
- 164.11
- Following holdings
- 5,360
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-06
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 3399
- transaction Price Per Share: 164.11
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 5360
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Cain Wettan Keeley M: EVP Gen Counsel, Legal & Comp.
- The filing reports a Rule 10b5-1 trading plan.
- F1: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 07, 2026.
Original sources
Prepared automatically from public filing data. Report a correction.